Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8)

BACKGROUND: Results from recent clinical trials on bone marrow mononuclear cell (BM-MNC) transplantation show that this intervention can help reduce the incidence of heart failure (HF) after acute myocardial infarction (AMI). However, no study has evaluated the effect of the transplantation of mesen...

Descripción completa

Detalles Bibliográficos
Autores principales: Attar, Armin, Monabati, Ahmad, Montaseri, Mohammad, Vosough, Massoud, Hosseini, Seyed Ali, Kojouri, Javad, Abdi-Ardekani, Alireza, Izadpanah, Peyman, Azarpira, Negar, Pouladfar, Gholamreza, Ramzi, Mani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351242/
https://www.ncbi.nlm.nih.gov/pubmed/35927674
http://dx.doi.org/10.1186/s13063-022-06594-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351242/
https://www.ncbi.nlm.nih.gov/pubmed/35927674
http://dx.doi.org/10.1186/s13063-022-06594-1

Ejemplares similares